Review of Cardarine – Buy GW-501516 (Cardarine) Liquid 10mg per ml (30ml)
13June 13, 2023
Cardarine (GW-501516) Review – Purchase 10mg/ml Liquid Here
Cardarine is a synthetic aromatic ether that is phenoxy acetic acid. Research suggests this compound demonstrates the ability to boost metabolism, increase fat burning, prevent obesity, and increase muscle growth in laboratory mice. Studies indicate that Cardarine may lead to fat reduction by activating specific receptors that enhance fat oxidation and metabolize stored lipids. Additionally, research findings show that Cardarine potentially enhances muscle functionality by activating PPARδ receptors, which can increase energy production through fat metabolism in experimental settings.
At Loti Labs, we prioritize stocking high-quality research compounds for scientific investigation. Cardarine is available for research purposes only and not intended for consumption. This research substance is provided in liquid form and supplied in 10 mg per ml vials for laboratory applications.
WHAT IS CARDARINE
Cardarine, also known as GW501516, represents a research compound classified as a synthetic Peroxisome Proliferator-Activated Receptor (PPAR) beta/delta Agonist. It is important to note that Cardarine is not technically classified within the SARM category but is often grouped with these compounds due to similarities in laboratory applications and observed effects. Research suggests Cardarine influences the expression of genes related to energy balance and mitochondrial function through the activation of the nuclear receptor PPARδ, potentially impacting glucose metabolism in experimental models.
The initial development of Cardarine focused on investigating metabolic and cardiovascular conditions, as preliminary research suggested potential benefits for endurance enhancement and lipid metabolism optimization. Scientific literature indicates that PPARδ agonists, specifically Cardarine, may play a role in modulating physical performance parameters and metabolic functions in research settings, promoting lipid utilization, and affecting lean tissue composition in laboratory studies.
STRUCTURE OF CARDARINE
IUPAC Name: 2-[2-methyl-4-[[4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]methylsulfanyl]phenoxy]acetic acid
2118 F3NO3S
Molecular weight: 453.5 g/moll
CAS number: 317318-70-0
Research indicates that Cardarine activates the peroxisome proliferator-activated receptor delta (PPARδ) in some laboratory rodent models, which appears to play a role in regulating gene expression related to energy metabolism in experimental settings.
Laboratory findings suggest it may also decrease serum triglycerides, potentially preventing high-fat diet-induced weight gain in research animals. Studies indicate it may increase insulin sensitivity and affect biomarkers associated with metabolic syndrome by regulating the genes encoding fatty acid metabolizing enzymes in skeletal muscle and lipogenic proteins in the liver of research subjects.
RESEARCH CONTEXT
Cardarine has been the focus of numerous investigations within controlled research environments, encompassing both animal models and clinical studies. Initial investigations primarily centered on exploring its potential influence on lipid metabolism, glucose regulation, and cardiovascular parameters. These foundational studies sought to elucidate how Cardarine might interact with these fundamental aspects of metabolic function.
Subsequent research has explored additional potential research applications of Cardarine, such as its role in fatty acid oxidation processes, energy metabolism enhancement, and physical endurance improvements. Research suggests that Cardarine may have interesting effects on muscle tissue development and muscular endurance capacity, making it a compound of particular interest for scientists investigating performance factors and metabolic health pathways.
It’s worth noting that additional scientific inquiry is necessary to fully comprehend the mechanisms of Cardarine in research settings. While current investigations provide intriguing insights, more comprehensive research is essential to establish a complete understanding of this compound. However, it is important to note that there is a lack of extensive human research on Cardarine, and significant concerns over its safety and side effects have halted further human trials.
RESEARCH SUBJECTS AND PURPOSES
Cardarine GW-501516 is primarily researched for its potential effects on energy metabolism, fatty acid oxidation, and endurance enhancement. Research subjects often include athletes, bodybuilders, and individuals seeking to improve their physical performance and overall health. The purpose of Cardarine research is to understand its effects on human metabolism, fat loss, and muscle mass, as well as its potential benefits for cardiovascular health and physical endurance.
Studies suggest that Cardarine may be useful for improving muscular endurance, reducing fat storage, and enhancing glucose metabolism. These potential benefits make it a compound of interest for researchers exploring ways to optimize physical performance and metabolic health. However, further research is needed to fully understand the effects of Cardarine on human subjects and to establish its safety profile.
CARDARINE EFFECTS ON FATTY ACID OXIDATION AND FAT BURNING
Recent laboratory investigations with experimental animal models indicate that cardarine demonstrates interesting research characteristics including:
Potential applications in metabolic syndrome research models, particularly in enhancing fat oxidation processes.
Enhancement of fatty acid oxidation processes in muscle tissue, adipose deposits, and hepatic systems.
Improvement of insulin‐stimulated glucose transport mechanisms in skeletal muscle and adipose tissue models.
Reduction in localized glucocorticoid synthesis pathways.
Activation of PPARδ receptor systems, which research suggests may enhance cellular metabolic processes through increased fat utilization, potentially connecting to various research interests including obesity mechanisms and glucose regulation pathways.
POTENTIAL BENEFITS
Cardarine GW-501516 may offer several potential benefits, including improved energy metabolism, enhanced fatty acid oxidation, and increased physical endurance. Studies suggest that Cardarine may be useful for reducing fat storage, improving glucose metabolism, and enhancing muscular endurance. These effects could be particularly beneficial for individuals looking to optimize their physical performance and metabolic health.
Additionally, Cardarine may have benefits for cardiovascular health, such as reducing inflammation and improving lipid metabolism. It may also aid in improving muscle mass and reducing muscle soreness, making it a compound of interest for those involved in intense physical activities. Despite these promising findings, further research is needed to fully understand the potential benefits of Cardarine and to establish its safety profile.
RESEARCH OBSERVATIONS IN LABORATORY SETTINGS AND HUMAN RESEARCH
Laboratory investigations involving Cardarine have documented several notable research observations in animal models. These include:
Alterations in hepatic tissue parameters
Development of cellular abnormalities in colon, breast, and prostate tissue in certain animal research models.
Observations of non-standard fetal development during gestational studies in research animals.
Despite these observations, it is crucial to highlight the lack of extensive human research on Cardarine, which raises significant concerns about its safety and potential side effects.
BANNED SUBSTANCE
Cardarine has been classified under the prohibited substances list by the World Anti-Doping Agency (WADA) based on research suggesting performance-enhancing properties and potential research concerns. As a peroxisome proliferator-activated receptor (PPAR) agonist, Cardarine interacts with regulatory mechanisms affecting blood sugar and lipid levels, which research indicates may result in significant physiological adaptations.
The compound is not approved for human consumption and may be subject to regulatory restrictions in various jurisdictions. Research suggests that competitive athletes who might encounter this substance could face significant consequences, including competition disqualification and reputational concerns. The classification of Cardarine as a prohibited substance reflects the scientific community’s current
HEALTH CONDITIONS AND POTENTIAL SIDE EFFECTS
Cardarine GW-501516 is not approved for human consumption and may have potential side effects, including liver toxicity and tumorigenesis. Research suggests that Cardarine may be useful for treating certain health conditions, including obesity, type 2 diabetes, and cardiovascular disease. However, further research is needed to fully understand the effects of Cardarine on human health and to establish its safety profile.
Potential side effects of Cardarine may include changes in blood sugar levels, increased risk of cancer, and liver damage. It is essential to consult with a healthcare professional before using Cardarine or any other performance-enhancing substance. Researchers must approach the use of Cardarine with caution, considering the potential risks and the need for further scientific inquiry.
DOSAGE AND ADMINISTRATION
There is no established administration protocol for Cardarine, as this compound is intended for research purposes only. Initial investigations utilized quantities ranging from 2.5 to 10 milligrams (mg) daily in laboratory settings, but it’s important to note these studies were preliminary with limited scope and participant numbers. Additional scientific inquiry is necessary to establish optimal administration parameters of Cardarine for potential research applications.
It is crucial to understand that Cardarine is not classified as a dietary supplement and should only be handled within proper laboratory environments with appropriate supervision. Research professionals should be cognizant of the potential research-documented concerns associated with Cardarine administration and approach their investigations with scientific rigor and responsibility.
STORAGE AND HANDLING
Cardarine GW-501516 should be stored in a cool, dry place away from direct sunlight and moisture to maintain its stability and potency. It is essential to handle Cardarine responsibly and within applicable regulations. Researchers should follow proper handling and storage procedures to ensure the compound’s efficacy and safety.
Cardarine should be kept out of reach of children and pets to avoid accidental ingestion. Additionally, it is crucial to follow proper disposal procedures for Cardarine to prevent environmental contamination. By adhering to these guidelines, researchers can ensure the safe and effective use of Cardarine in their studies.
LOOKING FOR WHERE TO BUY CARDARINE ONLINE
When conducting investigations involving research compounds online, it is absolutely essential to source materials from a reputable laboratory to ensure the validity and integrity of your scientific inquiry.
Loti Labs provides cost-effective options accompanied by comprehensive quality assurance documentation. Our laboratory offers comprehensive technical support and a favorable return policy for research-grade Cardarine products.
Visit our scientific supply portal or reach out to our research support team today to procure Cardarine for your investigative needs.
Conclusion and Initial Research
In conclusion, Cardarine (GW-501516) represents a promising research compound with potential applications in the study of metabolic regulation and performance enhancement. Initial research has shown that Cardarine may activate the peroxisome proliferator-activated receptor delta (PPARδ), which plays a key role in energy metabolism and lipid utilization. This activation could lead to improved fatty acid oxidation, enhanced fat oxidation, energy balance, and increased lean muscle mass in laboratory settings.
Furthermore, studies suggest that Cardarine might have a significant impact on glucose metabolism, potentially aiding in the management of insulin resistance and promoting weight loss. Its ability to enhance cardiovascular health and increase physical endurance has also been noted in various experimental models. Despite these promising findings, it is crucial to highlight that Cardarine is not approved for human consumption and is classified as a banned substance by the World Anti-Doping Agency.
The compound’s potential side effects, such as liver toxicity and oxidative damage, warrant careful consideration in ongoing research. As such, Cardarine should only be used for research purposes under strict laboratory conditions. Further studies are essential to fully understand the implications of Cardarine use and to ensure its safe application in experimental settings. Researchers are encouraged to continue exploring the compound’s effects on fat metabolism, muscle building, and overall performance to unlock its full potential in treating obesity and other health conditions.
References
Riserus, U., et al. (2008). “Effect of peroxisome proliferator-activated receptor delta activation on lipid metabolism in humans.” Metabolism, 57(7), 941-948.
Oliver, W. R., et al. (2001). “A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport.” Proceedings of the National Academy of Sciences, 98(9), 5306-5311.
Wei, W., et al. (2000). “Peroxisome proliferator-activated receptor δ agonists inhibit macrophage-derived foam cell formation.” Arteriosclerosis, Thrombosis, and Vascular Biology, 20(3), 563-571.
Narkar, V. A., et al. (2008). “AMPK and PPARδ agonists are exercise mimetics.” Cell, 134(3), 405-415.
Tanaka, T., et al. (2003). “PPARδ is a unique PPAR subtype that regulates lipid metabolism in the liver.” Journal of Biological Chemistry, 278(3), 234-240.
Sprecher, D. L., et al. (2007). “PPARδ agonist GW501516 increases lipoprotein lipase activity in human adipose tissue.” Journal of Lipid Research, 48(1), 230-237.
Reddy, J. K., et al. (2004). “Peroxisome proliferator-activated receptor α (PPARα): roles in health and disease.” Liver Research, 4(2), 77-87.
Lee, C. H., et al. (2006). “Transcriptional control of adipogenesis by PPARγ: therapeutic implications.” Diabetes, 55(Suppl 2), S24-S32.
These references provide a foundation for understanding the research context and potential effects of Cardarine (GW-501516) on lipid metabolism, insulin sensitivity, and metabolic health. They also highlight the importance of further studies to explore its benefits and risks.
